A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochest...
SoniVie recently announced that on 5 May 2022 the US Food and Drug Administratio...
Conformal Medical has announced the launch of the CONFORM pivotal trial with...
The National Institute for Health and Care Excellence (NICE) has recommended...
Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO...
Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston...
Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip t...
Data from the first report on patients with a pacemaker lead across the tric...
AtriCure has announced that the first patient has been treated in the HEAL-IST t...
The potential to utilise artificial intelligence (AI) or machine learning in c...
This advertorial is sponsored by Adept Medical. Outlining Adept Medical’s pro...
A retrospective review of more than 24,000 patients who underwent an electrocard...
Filterlex Medical has announced results from a first-in-human (FIH) study de...
A study has revealed the “global collateral damage” caused by the disruption to ...
 A new consensus statement—in development from the European Society of Cardi...
 “At the moment, tricuspid is the valve where most things are happening,” sa...
Transcatheter aortic valve implantation (TAVI) was found to be non-inferior ...
The use of distal radial artery access for percutaneous coronary interventio...
Concurrent tricuspid valve surgery and left ventricular assist device (LVAD)...
 Robotic-assisted percutaneous coronary intervention (PCI) has the potential...
New data confirming one-year outcomes with coronary intravascular lithotrips...
Sunil Rao (Duke University Health System, Durham, USA) has assumed the offic...
Endotronix has announced data from the SIRONA 2 clinical trial evaluating sa...
Shockwave Medical and Genesis MedTech Group announced today that they have succe...
Adept Medical says it has responded to the call from interventional radiolog...
 Transcatheter tricuspid valve repair potentially offers a “less risky” opti...
One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Ed...
 Matti Adam (Cologne, Germany) talks to Cardiovascular News about the evolut...
Use of the cusp overlap technique for the deployment of devices in transcath...
Results of the 20-patient, first-in-human clinical study supporting the safety a...
Patients in England with ST-elevation myocardial infarction (STEMI) had an a...
 “Renal denervation has travelled a very storied path over the last 10–15 ye...
Analysis of data from a US-wide health system suggests that the volume of percut...
Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, F...
New data on robotic-assisted percutaneous coronary intervention (PCI) have been ...
Vivasure Medical has announced the closing of the first tranche of €22 million (...
Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR...
Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France...
Medtronic has announced that it has received US Food and Drug Administration (FD...
In this issue: New data hint at positive performance of TAVI on structural ...
In this issue: New data hint at positive performance of TAVI on structural ...
A US analysis comparing trends in transcatheter and surgical mitral valve repair...
Abbott has announced a new partnership with Women as One to launch a new program...

Vijay Kunadian

Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Founda...
This advertorial is sponsored by Siemens Healthineers In the modern cath lab,...
This advertorial is sponsored by Medtronic Due to the growth of transcath...
The most read stories from across Cardiovascular News in April 2022 include high...
At the 2022 Charing Cross (CX) International Symposium (26–28 April, London,...
This educational supplement, sponsored by Medtronic, explores the science underp...
In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 ...
OpSens has announced that it has received Health Canada approval for the SavvyWi...
Biosensors International Group has announced both the Japanese Pharmaceutica...
Medtronic has announced the first patient enrolment in the EXPAND TAVR II pi...
Medtronic has announced that Laura Mauri has been appointed as the company’s chi...
The Society for Cardiovascular Angiography & Interventions (SCAI) has releas...
Translumina has announced the launch of Vivo Isar, its latest generation dual dr...
The pandemic saw a boom in the use of remote technologies and telehealth for...
Corindus, a Siemens Healthineers company, announced today the opening of its new...
Transit Scientific has announced US Food and Drug Administration (FDA) clear...
Quest International and CathWorks have announced a strategic partnership. Qu...
Viz.ai has raised a US$100 million funding round at a US$1.2 billion valuation, ...

VenusP-Valve gains CE mark

Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—Venus...
CeloNova BioSciences has announced the strategic decision to focus its core ...
Patients treated with edoxaban for six months after a transcatheter aortic v...
The most read stories from across Cardiovascular News in March 2022 include a we...
FEops has announced that it received authorisation from the US Food and Drug...
Abiomed has announced that the first patient in Japan has been treated succe...
Biosensors International has announced the enrolment of the first patient in the...
Patients who received a transcatheter supra-annular self-expanding heart valve h...
Latest results from the North American COVID-19 STEMI (NACMI) registry repor...
A head-to-head comparison of fractional flow reserve (FFR) and intravascular ult...
Long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial have be...
Patients with tricuspid regurgitation (TR) who received a Pascal transcatheter v...
Corvia Medical has announced publication of analyses from its global, phase ...
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (...
East End Medical has announced the first commercial use of its SafeCross tra...
Royal Philips is launching an echocardiography image analysis and reporting solu...
The Society for Cardiovascular Angiography & Interventions (SCAI) has releas...
Edwards Lifesciences has announced it received approval from the US Food and Dru...
Shockwave Medical’s C2 coronary intravascular lithotripsy (IVL) catheter has rec...
Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V ...
Investigators have completed enrolment in the RADIANCE-II pivotal trial of the P...
Carmat, designer and developer of an advanced total artificial heart, has is...
Researchers have detailed the use of an artificial intelligence-enabled tool...
Cardiawave has announced the success of its first-in-human I (FIH I) safety and ...
A consensus document outlining design principles and outcome definitions for dev...
Four radial cases using the PH Band System (Medical Ingenuities)—a novel med...
Venus Medtech has appointed Shakeel Osman as senior vice president of sales Euro...
Women are less likely to receive lifesaving treatment for cardiogenic shock than...
Only 76% of heart attack patients with dyspnoea or fatigue as their main symptom...
Nick West, chief medical officer and divisional vice president of Global Med...
Xeltis has announced promising initial outcomes from two key vascular trials inv...
The American College of Cardiology (ACC) has issued an expert consensus decision...
Cardiovascular Systems—CSI—has announced the first in-human experience with Prop...
Vivasure Medical has announced today that the first patient was treated in a...
A new strategy using telehealth to monitor blood pressure at home for severa...
“When I was one year old, my father died in the war between Israel and Egypt...
Big Sky Biomedical has appointed Ryan Egeland as managing director. “Big ...
Medtronic has announced that it has entered into a contract with Vizient to ...
The most read stories from across Cardiovascular News in February 2022 include t...
Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical out...
A novel transcatheter system designed for transfemoral mitral valve repair—t...
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual ...
Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aort...
Levels of high-sensitivity troponin I after cardiac surgery that were associated...
Biotronik has announced final enrolment in the BIOMAG-I clinical trial by Mi...
Results from a new analysis assessing real-world outcomes with the Watchman ...
Women remain underrepresented in leading cardiovascular clinical trials, cor...
Results from the first animal study of the Tria transcatheter aortic valve (...
Final five-year results from the BIOFLOW-V trial, presented during a late-br...
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to thi...
Wearable technology and digital health specialist Activinsights has announced a ...
Patients with both a high lipoprotein(a) and high coronary artery calcium sc...
Anticipation is building for the Charing Cross International Symposium 2022 ...
Teleflex has announced that the US Food and Drug Administration (FDA) has cleare...
Historically, catheter ablation has been reserved for atrial fibrillation (A...
Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated...
Siemens Healthineers has announced the launch of Artis icono biplane—an angiogra...
The “Ross procedure” may be a more favourable option for aortic valve replac...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary a...
Consultation by a heart team led to an observed benefit in objective patient out...
Researchers have developed a novel method of measuring growth of thoracic aortic...
Cardiologist and researcher Robert Califf has been confirmed as the commissi...
Robotic systems have the potential to fundamentally change the way care is deliv...
The donation of new 3D printing technology to the Visible Heart Laboratories...
Elixir Medical has announced completion of enrolment in the BIOADAPTOR rando...
Boston Scientific has announced the close of its acquisition of Baylis Medic...
MedHub has announced the completion of a funding round worth US$1 million in new...
The Supreme healing-targeted drug-eluting stent (Sinomed) is effective and s...
Peter Haworth (Portsmouth Hospitals University NHS Trust, Portsmouth, UK) docume...
HeartFlow has announced that it and Longview Acquisition Corporation have mutual...
Lung cancer patients with higher amounts of coronary artery calcium have an incr...
The use of intravascular ultrasound (IVUS) guidance for implantation of drug-elu...
The most read stories from across Cardiovascular News in January 2022 include co...
Acarix has submitted a breakthrough designation request for its technology for h...
The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundati...
Royal Philips has announced an update to its handheld ultrasound platform—Lumify...
Atheart Medical has announced that it has received US Food and Drug Administ...
The placement of an interarterial shunt device—the Corvia atrial shunt (Corv...
Biosensors has announced the enrolment of the first patient in the RISE SC study...
BioCardia has announced that the US Food and Drug Administration (FDA) has grant...
CroíValve has raised a Series A round to fund a feasibility clinical study w...
Black adults born in the USA had a higher rate of death from cardiovascular ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has an...
Abbott has released a second round of insights from its Beyond Intervention ...
This advertorial is sponsored by Shockwave Medical. The latest data from the ...
This advertorial is sponsored by Medtronic. Evolut PRO+ is the latest generat...

Susheel Kodali

Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in...
In this issue:  Coronary revascularisation guidelines spark debate New d...
In this issue:  Coronary revascularisation guidelines spark debate New d...
Insights from what was described as the “largest and most comprehensive” ana...
Artivion has announced the publication of PROACT clinical trial results in The A...
The Society for Cardiovascular Angiography and Interventions (SCAI) has rele...
Cardiothoracic surgeon John H Calhoon from The University of Texas Health Sc...
Patients with mitral valve disease who live in disadvantaged communities are...
InnovHeart, developer of novel transcatheter mitral valve replacement (TMVR) sys...

JIM 2022 moves to June slot

Organisers of the Joint Interventional Meeting (JIM) have announced that the 202...
The first patient has been enrolled in the TRANSFORM II randomised controlle...
Radiation exposure during percutaneous coronary intervention (PCI) has fallen “c...
Researchers have warned that the number of people suffering from aortic valve st...
The US Food and Drug Administration (FDA) has issued two final guidances providi...
Congenita has been named a recipient of the MedTech NAVIGATOR Innovation Grant S...
A review evaluating the results of thoracic endovascular aortic repair (TEVA...
New clinical practice guidelines have been published today, and are intended to ...
CytoSorbents has called attention to a new publication which reports on the use ...
Cardiovascular Systems (CSI) and OrbusNeich Medical Company have announced US Fo...
WL Gore & Associates has announced that its Cardioform Septal Occluder h...
In a joint programme between the Society of Thoracic Surgeons (STS) and the ...
A new study reports that watching TV for four hours a day or more is associated ...
Royal Philips today announced physicians will now have access to advanced ne...
New guidelines from the American College of Cardiology (ACC) and the American He...
Cardiovascular Systems recently announced that it has made significant progress ...
A propensity score-matched analysis of the early outcomes of transcatheter aorti...
A 57-year-old patient with terminal heart disease received a successful transpla...
The American Association for Thoracic Surgery (AATS) and The Society of Thoracic...
The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an...
Terumo Medical Corporation has welcomed the publication of updated guidelines fr...
Robocath has announced the conclusion of its R-Evolution clinical study in Europ...
Regulators in three countries have granted approvals to Impella surgical product...
Medtronic has announced that the National Medical Products Administration (N...
The most read stories from December 2021 include analysis of the CHEETAH study a...
Neovasc has announced enrolment of the first patient in the COSIRA-II clinical t...
Endotronix has announced that the US Food and Drug Administration (FDA) has ...
Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partne...
Vesalio recently announced the start of enrolment in its NATURE study using enVa...
Royal Philips has announced US Food and Drug Administration (FDA) de novo cl...
Foldax has announced publication of the first clinical results for its Tria ...
Edwards Lifesciences has received approval from the US Food and Drug Adminis...
Doctors at St David's Medical Center in Austin, USA recently implanted a new neu...
Many patients undergoing cardiac surgery may be able to safely and effectively c...
FAST BioMedical has announced the publication of additional results from the EMP...
Thubrikar Aortic Valve has received approval from a Competent Authority in Polan...
Ultromics has announced the publication of a study assessing its EchoGo plat...
HeartFlow has announced it has submitted a 510(k) premarket application to the U...
Results of the CHEETAH clinical study highlight the potential role of mechan...
Svelte Medical Systems has received US Food and Drug Administration (FDA) approv...
Opsens has filed a 510(k) submission with the US Food & Drug Administration ...
The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the...
The likelihood of patients with suspected or known coronary artery disease dying...
Huge strides have been made in preventing contrast-associated acute kidney i...
New guidelines for coronary artery revascularisation recommend that treatment de...
A team led by investigators at Massachusetts General Hospital (MGH) in Boston, U...
RSIP Vision has announced a new coronary artery modelling technology, which enab...
Royal Philips has announced an expansion of its ultrasound portfolio with ne...
Foldax has announced that the Drugs Controller General of India (DCGI), India’s ...
Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitr...
SyMap Medical has announced the completion of a financing round which will b...
Restore Medical has announced preliminary results of the first-in-human clinical...
 The first analysis of findings from the bRIGHT registry, detailing rea...
One in 10 junior doctors training to be cardiologists in the UK say they have be...
Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceu...
Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meet...
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunc...
Soundbite Medical Solutions has announced that the US Patent and Trademark Offic...
Robocath has announced the successful completion of what it has described as the...
Findings of the CHOICE MI registry show that transcatheter mitral valve impl...
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI...

Mirvat Alasnag

Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Cu...
Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic...
First clinical results of transcatheter aortic valve implantation (TAVI) usi...
The first 30-day results following the implantation of the NeoChord NeXuS tr...
Opsens has announced the successful treatment of 20 patients leading to the comp...
The Minneapolis Heart Institute Foundation (MHIF; Minneapolis, USA) has announce...
The first patients have been enrolled in the FAST III trial at the Erasmus Unive...
European Society of Cardiology (ESC) guidance for the diagnosis and management o...
New guidance on the diagnosis and presentation of cardiogenic shock aims to ...
A meta-analysis comparing percutaneous coronary intervention (PCI) using a d...
Nonagenarians should not be refused transcatheter aortic valve implantation (TAV...
An updated risk score to predict possible contrast-associated acute kidney i...
Use of a novel, venous external support device (VEST, Vascular Graft Solutio...
HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance t...
Coronary artery bypass graft sugery (CABG) between two and three days after tica...
Asymptomatic patients with severe aortic stenosis (AS) may benefit from early ao...

What to expect from AHA 2021

Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2...
This advertorial is sponsored by iVascular Treatment of a chronic total occlu...
Early data presented at the Transcatheter Cardiovascular Therapeutics annual...
Caption Health and Ultromics have announced a strategic partnership to accelerat...
Abbott has released new research from its Beyond Intervention initiative, a mult...
SIS Medical AG has appointed Ron Waksman, associate director Division of Car...

Lessons from SURTAVI

Transcatheter aortic valve implantation (TAVI) pioneer and principal investigato...
Cardiovascular Systems has announced the start of enrolment in a first in-human ...
Patients who went into cardiac arrest in the cardiac cath lab were more likely t...
CoreMedic has announced the publication of two-year follow-up results from the f...
Medtronic has announced its ambition to achieve net zero carbon emissions by fis...
Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascul...
Six-month results from the TRISCEND study of the Evoque (Edwards Lifescience...
Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral ...
Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovasc...
Patients receiving antiplatelet therapy following percutaneous coronary inte...
The final results of the PROTECT III and Restore EF prospective studies demo...
Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K...
Five-year clinical and echocardiographic outcome data from the SURTAVI rando...
Results from the largest randomised trial to date comparing different closur...
An economic analysis of data from the PARTNER 3 randomised trial, comparing ...
Penumbra has announced that the CHEETAH clinical study of its Indigo system ...
One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravasc...
Results from SUGAR, a randomised controlled, multicentre trial conducted exclusi...
Randomised placebo-controlled trials show consistently that renal denervation pr...
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing en...
Lesion selection for percutaneous coronary intervention (PCI) using the non-inva...
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (...
Medtronic has announced findings from a new study of patient preferences for the...
In this issue:  MASTER DAPT game changing for short-duration dual antiplate...
In this issue:  MASTER DAPT game changing for short-duration dual antiplate...
Royal Philips has previewed updates in its product portfolio and new data due to...
Procyrion has announced the presentation of studies at the Transcatheter Cardiov...
Hypertension health-tech firm Aktiia has announced a US$17.5 million Series ...
ReValve Solutions has announced that it has successfully completed the first-in-...
Results from two studies of the Impella heart pump device will be presented at t...
This educational supplement, sponsored by Medtronic, explores the latest evidenc...
Joint clinical practice guidelines have been issued by the American Heart Associ...
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACT...
The longest available real-world follow-up data of transcatheter mitral ...
Teleflex announced the completion of patient enrolment in a clinical study evalu...
Patients who survive an aortic dissection often fail to receive ​​comprehens...
The Cardiovascular Research Foundation (CRF) has announced that the digital comp...
Sinomed has announced that the PIONEER III clinical trial results for its HT...
Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) im...
JenaValve Technology has announced the first commercial implants with the Trilog...
HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate t...
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has p...
Ethnic and racial minority cardiologists report career satisfaction but face pro...
“We are at the beginning of a type A dissection revolution,” Joseph E Bavari...
The underrepresentation of women in clinical coronary revascularisation tria...
OpSens has announced the commencement of the human clinical study utilising the ...
Building and maintaining expertise in both open and endovascular surgical te...
ReCor Medical has announced that its Paradise ultrasound renal denervation syste...
Baylis Medical Company has reached an agreement to sell its cardiology business ...
In a session on “Reduction of radiation challenges” at CX Aortic Vienna 2021...
Bert van Meurs is the chief business leader for Image Guided Therapy within Roya...
A decisive vote at CX Aortic Vienna 2021 (5–7 October, broadcast) revealed t...
Results of a poll conducted at CX Aortic Vienna 2021 (5–7 October, broadcast...
A worldwide committee of 40 cross-specialty medical experts achieved the fir...
NeoChord has announced successful completion of the first-in-human procedure wit...
Top stories for September included more highlights from the European Society of ...
Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, ...
The US Food and Drug Administration (FDA) has informed healthcare providers of r...
Foldax has announced completion of enrolment in the US early feasibility study o...
Cardiovascular Systems recently announced that the first patient has been succes...
Siemens Healthineers has launched the Luminos Impulse fluoroscopy system, includ...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
Biotronik has announced that it has received US Food and Drug Administration...
Patients awaiting coronary artery bypass grafting (CABG) or percutaneous cor...
Open Stent Solution (OSS) has announced the closing of a €2.5 million Seed finan...
The Heart Rhythm Society (HRS) has announced that its cardiovascular digital hea...
Capturing the latest developments in the comprehensive treatment of aortic disea...
This advertorial is sponsored by Medtronic As transcatheter aortic valve ...
 George Dangas (New York, USA) discusses the results of the TWILIGHT-Stent tri...
Neovasc has announced that it has received Food and Drug Administration (FDA) ap...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
Patients at low surgical risk who had undergone transcatheter aortic valve i...
A cardiothoracic surgical team with UofL Health–Jewish Hospital and the Univ...
Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI...
Randomised trials are needed to evaluate the safety and effectiveness of tra...
Abbott has announced that the US Food and Drug Administration (FDA) has appr...
OpSens has announced that it has received Health Canada approval to commence the...
Following the release of the European Society of Hypertension’s (ESH’s) upda...
One-year data from preclinical trials of Xeltis restorative coronary artery bypa...
The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking ...
European Society of Hypertension (ESH), the leading hypertension (HTN) society i...
Peijia Medical has announced the initiation of its multicentre clinical tria...

Christoph Naber

Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career i...
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potentia...
CytoSorbents has filed an investigational device exemption (IDE) application to ...
STENTiT, a medical device company bringing a novel class of regenerative end...
When a modified surgical technique was used to gently remove sections of leg vei...
Concept Medical has announced the enrolment of the thousandth patient in ABILITY...
“During a heart attack time is myocardium,” says Annapoorna Kini (New York, ...
Adults younger than 45 years who reported recently using cannabis were two times...
August’s top 10 features a stark warning over representation of women in clinica...
HeartFlow has announced that physicians at Erasmus MC Hospital (Rotterdam, T...
Findings of the STOPDAPT-2 ACS trial presented during a hot line session at ...
Abbott has announced late-breaking data from the Amulet LAA Occluder IDE tri...
Work stress, sleep disorders, and fatigue—which are regarded as non-traditional ...
 Marco Valgimigli (Lugano, Switzerland) talks to Cardiovascular News abo...
Adding systematic fractional flow reserve (FFR) assessment to coronary angio...
MedAlliance today announced first patient enrolment in the coronary randomised c...
Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients...
Edoxaban is noninferior to warfarin and its analogues for adverse clinical e...
One month of dual antiplatelet therapy (DAPT) following stent implantation i...
The world’s first feasibility study has found that drones can be used to deliver...
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatm...
Adherence to lifestyle advice and medications could add seven healthy years of l...
CARMAT has announced the second centre implanting its bioprosthetic artificial h...
Medtronic has announced US Food and Drug Administration (FDA) approval of its ne...
Young heart attack victims are more likely to be smokers, obese, and have hi...
Cardiac Dimensions has announced the launch of the US pivotal study the EMPO...
Readmissions within 30 days are more common following urgent, rather than el...
In this issue: Meta analysis draws out debate on coronary revascularisation...
In this issue: Meta analysis draws out debate on coronary revascularisation...
Translumina has announced the publication of 10-year clinical outcome data for i...
Ultromics, a developer of AI enabled cardiovascular imaging solutions, has annou...
The US Food and Drug Administration (FDA) has granted breakthrough device de...
Biotronik has announced the results from a new study published in EP Europace th...
Sinomed has announced the first commercial implantation of the HT Supreme dr...
Physicians at Mount Sinai Health System (New York, USA) have developed a mobile ...
CytoSorbents has been granted a second breakthrough device designation for its D...
Abbott has announced that the US Food and Drug Administration (FDA)  has app...
Occlutech Holding has announced the conditional US Food and Drug Administration ...
An imaging technology developed using artificial intelligence (AI) could become ...
Caption Health has announced that the Centers for Medicare and Medicaid Serv...
Women remain underrepresented in cardiovascular clinical trials despite initiati...
RealView Imaging has announced that it has received US Food and Drug Administrat...
With the COVID-19 pandemic having switched virtually all of the major meetin...
Our top 10 stories of July 2021, including: A milestone for coronary balloon ang...
The largest analysis of its kind to look at the impact of COVID-19 on adult ...
Abbott has announced that it has received US Food and Drug Administration (FDA) ...
Edwards Lifesciences has announced that it has received regulatory approval from...
The USA saw a 10% decline in percutaneous coronary intervention (PCI) proced...
Angel Medical Systems (AngelMed) has announced the first commercial implantation...
An analysis of the rates rehospitalisation and mortality in heart failure pa...
Medtronic has announced the launch of the Prevail drug coated balloon (DCB) cath...
This advertorial is sponsored by Medtronic The first case using the Preva...
CathWorks has announced that the Japanese Ministry of Health, Labour and Wel...
Among patients undergoing mitral valve surgery after failed transcatheter ed...
Clinical and economic results from the 3M TAVR economic study have been pres...
Patients with bicuspid aortic stenosis may benefit as much from transcathete...
Two-year results from the PINNACLE FLX clinical trial assessing the safety and e...
MedAlliance has launched Origin SC and Origin NC, two high performance balloons ...
Ancora Heart has closed US$80 million in equity financing, with the funds to...
HeartFlow has entered into a definitive business combination agreement with ...
Carmat has announced the first implantation of its bioprosthetic artificial hear...
Patients undergoing permanent pacemaker implantation after surgical aortic v...
atHeart Medical has announced the successful treatment of the first five pat...
East End Medical has announced it has received US Food and Drug Administrati...
Global action is needed to improve clinician wellbeing, according to four leadin...
Xeltis has announced that it has started a pivotal trial for a synthetic restora...
The American Heart Association (AHA) has published a scientific statement ch...
Our top 10 stories of June 2021, including: Analysis of the data for transcathet...
CytoSorbents has received approval for its investigational device exemption (IDE...
Carta Healthcare has announced that it has been certified as a National Cardiova...
Sinomed has announced a partnership with the National University of Ireland ...
Assessment of patients by both interventional cardiologists and cardiac surg...
Royal Philips has announced the first procedure using its real-time 3D intracard...
Abbott has today announced that its Xience family of stents has received US ...
Clinical practice guidance released today outline recommendations for reduci...
Electroducer has announced that it has raised €3 million (US$3.65M) from private...
The risk of heart damage from COVID-19 infection is far greater than that from r...
Heart attacks during the COVID-19 pandemic were more likely to result in hea...
Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (...
Nearly one in eight coronary artery bypass graft (CABG) patients are readmit...
The first end-to-end remotely guided transcatheter aortic valve implantation...
Abbott has received Breakthrough Device designation from the US Food and Dru...
Royal Philips has announced the official start of the DEFINE GPS study, with...
After speaking with experts, reviewing current evidence, surveying people living...
Data captured in the National Cardiovascular Data Registry (NCDR) is similar...
An investigation into the impact of postoperative complications on long-term qua...

Cindy Grines

Cindy Grines is an interventional cardiologist and chief scientific officer of N...
In patients with acute coronary syndrome treated with percutaneous coronary ...
The number of people dying from cardiovascular disease (CVD) in Asia is increasi...
CorWave has announced that it has successfully completed the first 90-day precli...
Circulation the flagship journal of the American Heart Association (AHA) has pub...
Shockwave Medical has announced today that the Centers for Medicare & Medica...
A study looking at the timing of coronary artery bypass grafting (CABG) after th...
Pivotal trials of transcatheter aortic valve implantation (TAVI) in low-risk...
Neurescue has announced that the US Food and Drug Administration (FDA) has grant...
A new physiological measurement of heart function could improve survival for...
Early experience with the Evoque (Edwards Lifesciences) tricuspid valve replacem...
GE Healthcare is collaborating with the American College of Cardiology (ACC) thr...
Medtronic is stopping the distribution and sale of the Medtronic HVAD system...